Yahoo Web Search

Mail

  1. Sort by

  1. Kineta Receives Wellcome Trust Award to Advance Novel Therapeutic for Lassa Fever Into Clinical Trials

    PR Newswire via Yahoo! FinanceMay 05 05:40 AM

    SEATTLE, May 5, 2016 /PRNewswire/ -- Kineta, Inc., a biotechnology company focused on the translational development of novel immune modulating and antiviral drugs announced today that the company will receive a Wellcome Trust Translation Fund Award of up to $7.2M.  This award will advance the development of a novel antiviral therapy to treat Lassa haemorrhagic fever. The funded collaboration ...

  2. Kineta Receives Wellcome Trust Award to Advance Novel Therapeutic for Lassa Fever Into Clinical Trials

    PR NewswireMay 05 06:11 AM

    SEATTLE, May 5, 2016 /PRNewswire/ -- Kineta, Inc., a biotechnology company focused on the translational development of novel immune modulating and antiviral drugs announced today that the company will receive a Wellcome Trust Translation Fund Award of up to $7.2M.  This award will...

  3. TSRI scientists reveal secrets of a deadly virus family

    EurekAlert!Apr 26 09:26 AM

    Scientists at the Scripps Research Institute have solved the structure of the biological machinery used by a common virus to recognize and attack human host cells. The new structure gives scientists the first view of the glycoprotein of lymphocytic choriomeningitis virus (LCMV), present on every continent except Antarctica. The research reveals important traits in LCMV and points to possible ...

  4. Scientists reveal secrets of a deadly virus family

    Science DailyApr 26 10:08 AM

    Scientists have solved the structure of the biological machinery used by a common virus to recognize and attack human host cells. The new structure gives scientists the first view of the glycoprotein of lymphocytic choriomeningitis virus (LCMV), present on every continent except Antarctica. The research reveals important traits in LCMV and points to possible drug targets on LCMV's close relative...

  5. Kineta Presents Promising New Data on Novel Lassa Fever Antiviral and Broad Spectrum Innate Immune Antivirals

    PR Newswire via Yahoo! FinanceApr 22 05:30 AM

    SEATTLE, April 22, 2016 /PRNewswire/ -- Kineta, Inc., a biotechnology company focused on the translational development of novel antiviral and immune modulating drugs presented promising new data on two ...

  6. TSRI study reveals important traits in LCMV, Lassa virus

    News-Medical-NetApr 27 12:56 PM

    For the first time, scientists at The Scripps Research Institute (TSRI) have solved the structure of the biological machinery used by a common virus to recognize and attack human host cells.

  1. 7 results